BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, activates of human NADPH oxidase system from THP-1 cells: a potential adjuvant for infection control of immunodeficient patients (2007)
- Autores:
- Autor USP: CONDINO NETO, ANTONIO - ICB
- Unidade: ICB
- Assunto: IMUNOLOGIA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Clinics
- Volume/Número/Paginação/Ano: v. 62, suppl. 2, 2007
- Nome do evento: LAGID Meeting of the Autoimmunity in Primary Immunodeficiencies
-
ABNT
OLIVEIRA, E. B. et al. BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, activates of human NADPH oxidase system from THP-1 cells: a potential adjuvant for infection control of immunodeficient patients. Clinics. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 18 abr. 2024. , 2007 -
APA
Oliveira, E. B., Thomazzi, S. M., Rehder, J., Antunes, E., & Condino Neto, A. (2007). BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, activates of human NADPH oxidase system from THP-1 cells: a potential adjuvant for infection control of immunodeficient patients. Clinics. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo. -
NLM
Oliveira EB, Thomazzi SM, Rehder J, Antunes E, Condino Neto A. BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, activates of human NADPH oxidase system from THP-1 cells: a potential adjuvant for infection control of immunodeficient patients. Clinics. 2007 ; 62[citado 2024 abr. 18 ] -
Vancouver
Oliveira EB, Thomazzi SM, Rehder J, Antunes E, Condino Neto A. BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, activates of human NADPH oxidase system from THP-1 cells: a potential adjuvant for infection control of immunodeficient patients. Clinics. 2007 ; 62[citado 2024 abr. 18 ] - Anhidrotic ectodermal dysplasia and T cell immunodeficiency
- BAY 41-2272 aumenta a atividade microbicida in vitro de leucócitos mononucleares humanos
- The role of nuclear factor kappa B (NF-kB) on the NCF1 gene expression
- Essential role of nuclear factor-kappa B for NADPH oxidase activity in normal and anhidrotic ectodermal dysplasia leukocytes
- A single nucleotide polymorphism in the promoter region of the NCF-2 gene
- Essential role of nuclear factor-kappa B for NADPH oxidase activity, CYBB and NCF-1 gene expression in normal and anhidrotic ectodermal dysplasia leukocytes
- An unusual case of a female patient presenting with recurrent infections due to mycobacteria, viruses, and pyogenic bacteria and defective TLRs response
- Critical issues and needs in management of primary immunodeficiency diseases in Latin America
- Brain abscess as first clinical manifestation of hypogammaglobulinemia
- Essential role of Nuclear Factor kappa B (NF-jB) on NCFL gene expression in normal, anhidrotic ectodermal dysplasia, and chronic granulomatous disease leukocytes
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
